I wouldn't recommend it for everyone
After putting together clinical findings, special studies on tissues (if needed) and with microscope findings, the pathologist arrives at a definitive diagnosis
FDA EGRIFTA WR Prescribing Information (revised March 2025): Official description of tesamorelin, its 44-amino-acid GRF sequence, N-terminal hexenoyl moiety, free-base-equivalent molecular weight, receptor pharmacology, and formulation-specific pharmacokinetics
Tirzepatide onset may also differ from semaglutide in immune-relevant contexts
It is critical to understand the difference between compounded and brand-name GLP-1 medications: Brand-name medications (Wegovy, Zepbound) are FDA-approved, manufactured under strict quality controls, and have been tested in large-scale clinical trials Compounded versions are not FDA-approved, meaning they have not undergone the same safety and efficacy testing In 2025, the FDA declared the shortage over, meaning compounding of semaglutide and tirzepatide is no longer legally permitted for most pharmacies Some compounded products have used different salt forms of semaglutide (such as semaglutide acetate instead of semaglutide sodium) that have not been shown to behave identically in the body Who Is a Good Candidate for GLP-1 Weight Loss Medication